Correction to Discovery of Novel 3-Quinoline Carboxamides as Potent

Addition/Correction Cite This: J. Med. Chem. XXXX, XXX, XXX−XXX

pubs.acs.org/jmc

Correction to Discovery of Novel 3‑Quinoline Carboxamides as Potent, Selective, and Orally Bioavailable Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase Sébastien L. Degorce,* Bernard Barlaam, Elaine Cadogan, Allan Dishington, Richard Ducray, Steven C. Glossop, Lorraine A. Hassall, Franck Lach, Alan Lau, Thomas M. McGuire, Thorsten Nowak, Gilles Ouvry, Kurt G. Pike, and Andrew G. Thomason Downloaded via 193.9.158.74 on July 4, 2018 at 02:01:54 (UTC). See https://pubs.acs.org/sharingguidelines for options on how to legitimately share published articles.

Journal of Medicinal Chemistry 2016, 59, 6281−6292. DOI: 10.1021/acs.jmedchem.6b00519 Page 6290. In the Experimental Section, the heading for the synthesis of molecule 72 should be “6-[6-(Methoxymethyl)-3pyridinyl]-4-{[(1S)-1-(tetrahydro-2H-pyran-4-yl)ethyl]amino}-3-quinolinecarboxamide (72)” instead of “6-[6-(Methoxymethyl)-3-pyridinyl]-4-{[(1R)-1-(tetrahydro-2H-pyran4-yl)ethyl]amino}-3-quinolinecarboxamide (72)”.

© XXXX American Chemical Society

A

DOI: 10.1021/acs.jmedchem.8b00936 J. Med. Chem. XXXX, XXX, XXX−XXX